A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity

European Journal of Clinical Pharmacology

Volumn 69, Issue 5, 2013, Pages 1057-1073

  Nasiri Toosi, Zahra ^a   Dashti Khavidaki, Simin ^a,b   Khalili, Hossein ^b   Lessan Pezeshki, Mahboob ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drug; Nephroprotective; Nephrotoxicity; Pentoxifylline; Renoprotective

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIMONY PENTACHLORIDE; CISPLATIN; CONTRAST MEDIUM; CYCLOSPORIN; DOXORUBICIN; GENTAMICIN; MEGLUMINE ANTIMONATE; METHOTREXATE; METHYLPREDNISOLONE; PENTOXIFYLLINE; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; CANDIDIASIS; CONTINUOUS INFUSION; CONTRAST INDUCED NEPHROPATHY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; EXPERIMENTAL ANIMAL; GRAFT VERSUS HOST REACTION; HUMAN; HYPERLIPIDEMIA; HYPOALBUMINEMIA; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY PERFUSION; KIDNEY TUBULE NECROSIS; MYCOSIS; NEOPLASM; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; REVIEW; SINGLE DRUG DOSE;

ACUTE KIDNEY INJURY; ANIMALS; ANTI-INFECTIVE AGENTS; CONTRAST MEDIA; CYTOTOXINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; PENTOXIFYLLINE; VASODILATOR AGENTS;

EID: 84879461204     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1452-x     Document Type: Review

References (85)

1. Nolin TD, Himmelfarb J (2010) Mechanisms of drug-induced nephrotoxicity. Handb Exp Pharmacol 196:111-130
2. Samlaska CP, Winfield EA (1994) Pentoxifylline. J Am Acad Dermatol 30:603-621 (Pubitemid 24121761)
3. Kreth S, Ledderose C, Luchting B, Weis F, Thiel M (2010) Immunomodulatory properties of pentoxifylline are mediated via adenosine-dependent pathways. Shock 34:10-16
4. Noel C, Copin MC, Hazzan M, Labalette M, Susen S, Lelievre G, Dessaint JP (2000) Immunomodulatory effect of pentoxifylline during human allograft rejection: involvement of tumor necrosis factor-alpha and adhesion molecules. Transplantation 69:1102-1107 (Pubitemid 30217593)
5. Savic V, Vlahovic P, Djordjevic V, Mitic-Zlatkovic M, Avramovic V, Stefanovic V (2002) Nephroprotective effects of pentoxifylline in experimental myoglobinuric acute renal failure. Pathol Biol 50:599-607 (Pubitemid 36033645)
6. Heystek HC, Thierry AC, Soulard P, Moulon C (2003) Phosphodiestrase 4 inhibitors reduce humen dendritic cell inflammatory cytokine production and Th1-polarizing capacity. Int Immunol 15:827-835 (Pubitemid 36827071)
7. Dousa TP (1998) Signaling role of PDE isozymes in pathobiology of glomelurar mesangial cells. Studies in vitro and in vivo. Cell Biochem Biophys 29:19-34 (Pubitemid 128533733)
8. Prasad K, Lee P (2007) Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism. Atherosclerosis 192:313-322 (Pubitemid 46726333)
9. Badri S, Dashti-Khavidaki S, Lessan-Pezeshki M, Abdollahi M (2011) A review of the potential benefits of pentoxifylline in diabetic and non-diabetic proteinuria. J Pharm Pharm Sci 14:128-137
10. Safarinejad MR (2011) Effect of pentoxifylline on semen parameters, reproductive hormones, and seminal plasma antioxidant capacity in men with idiopathic infertility: a randomized double-blind placebo-controlled study. Int Urol Nephrol 43:315-328
11. Berens KL, Luke DR (1990) Pentoxifylline in the isolated perfused rat kidney. Transplantation 49:876-879 (Pubitemid 20171951)
12. Albornoz LE, Sanchez SB, Bandi JC, Canteros G, de las Heras M, Mastai RC (1997) Pentoxifylline reduces nephrotoxicity associated with cyclosporine in the rat by its rheological properties. Transplantation 64:1404-1407 (Pubitemid 27513617)
13. Stojiljkovic N, Veljkovic S, Mihailovic D, Stoiljkovic M, Radenkovic M, Rankovic G, Randjelovic P (2009) Protective effects of pentoxifylline treatment on gentamicin-induced nephrotoxicity in rats. Ren Fail 31:54-61
14. Krysztopik RJ, Matheson PJ, Spain DA, Garrison RN, Wilson MA (2000) Lazaroid and pentoxifylline suppress sepsis-induced increases in renal vascular resistance via altered arachidonic acid metabolism. J Surg Res 93:75-81
15. Usta Y, Ismailoglu UB, Bakkaloglu A, Orhan D, Besbas N, Sahin-Erdemli I, Ozen S (2004) Effects of pentoxifylline in Adriamycin-induced renal disease in rats. Pediatr Nephrol 19:840-843 (Pubitemid 39144764)
16. Tedesco D, Haragsim L (2012) Cyclosporine: a review. J Transplant Epub 2012 Jan 4
17. Danovich GM (2010) Immunosuppressive medications and protocols for kidney transplantation. In: Danovich GM (ed) Hand book of kidney transplantation. Lippincott Williams and Wilkins, a Wolters Kluwer Health business, Philadelphia, 90
18. Brunner LJ, Vadiei K, Iyer LV, Luke DR (1989) Prevention of cyclosporine-induced nephrotoxicity with pentoxifylline. Ren Fail 11:97-104
19. Bennett WM, Elzinga LW, Porter GA, Rosen S (1992) The effects of pentoxifylline on experimental chronic cyclosporine nephrotoxicity. Transplantation 54:1118-1120 (Pubitemid 23005561)
20. Carrier M, Perrault LP, Tronc F, Stewart DJ, Pelletier CL (1993) Pentoxifylline decreases cyclosporine-induced renal endothelin release and vasoconstriction. Ann Thorac Surg 55:490-492 (Pubitemid 23060827)
21. Ates E, Sharma P, Erkasap S, Talbot D, Ihtiyar E, Yasar B, Kiper H (1996) Cyclosporine nephrotoxicity in the ischemic kidney and the protective effect of pentoxifylline - a study in the rat. Transplantation 62:864-867 (Pubitemid 26332856)
22. Potier M, Aparicio M, Cambar J (1997) Protective effect of three xanthine derivatives (theophylline, caffeine and pentoxifylline) against the cyclosporin A-induced glomerular contraction in isolated glomeruli and cultured mesangialcells. Nephron 77:427-434 (Abstract was used) (Pubitemid 27511194)
23. Kaputlu I, Sadan G, Karayalçin B, Boz A (1997) Beneficial effects of pentoxifylline on cyclosporine-induced nephrotoxicity. Clin Exp Pharmacol Physiol 24:365-369 (Pubitemid 27223830)
24. Shifow AA, Naidu MU, Kumar KV, Prayag A, Ratnakar KS (2000) Effect of pentoxifylline on cyclosporine-induced nephrotoxicity in rats. Indian J Exp Biol 38:347-352 (Abstract was used) (Pubitemid 30368728)
25. Bianco JA, Almgren J, Kern DL, Ballard B, Roark K, Andrews F, Nemunaitis J, Shields T, Singer JW (1991) Evidence that oral pentoxifylline reverses acute renal dysfunction in bone marrow transplant recipients receiving amphotericin B and cyclosporine. Results of a pilot study. Transplantation 51:925-927
26. Bianco JA, Appelbaum FR, Nemunaitis J, Almgren J, Andrews F, Kettner P, Shields A, Singer JW (1991) Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood 78:1205-1211
27. Peri A, Lang I, Gonzalez-Cabello R, Filep J, Nekam K, Gergely P, Feher J (1986) Indomethicin abrogates the suppression by cyclosporine A of lectin-dependent cell-mediated cytotoxicity to HEp-2 cells. Immunopharmacology 11:39-45 (Pubitemid 16148636)
28. Hang J, Thompson P, Beutler B (1990) Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separates points in the signaling pathway. J Exp Med 172:391-394 (Pubitemid 20217287)
29. Kalhs P, Lechner K, Stockschläder M, Krüger W, Peters S, Zander A (1992) Pentoxifylline did not prevent transplant-related toxicity in 31 consecutive allogeneic bone marrow transplant recipients. Blood 80:2683-2684
30. Stockschläder M, Kalhs P, Peters S, Zeller W, Krüger W, Kabisch H, Lechner K, Zander A (1993) Intravenous pentoxfylline failed to prevent transplant-related toxicities in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 12:357-362 (Pubitemid 23295519)
31. López J, Cancelas JA, Valiño JM, García-Laraña J, Sastre JL, Pérez-Oteyza J, Cerveró C, García-Avello A, Cabezudo E, Arranz MI (1994) Pentoxifylline is not useful in the prevention of toxicity associated with bone marrow transplantation. Med Clin 102:485-488 (Pubitemid 24117265)
32. Attal M, Huguet F, Rubie H, Charlet JP, Schlaifer D, Huynh A, Laurent G, Pris J (1993) Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial. Blood 82:732-736 (Pubitemid 23221650)
33. Clift RA, Bianco JA, Appelbaum FR, Buckner CD, Singer JW, Bakke L, Bensinger WI, Bowden RA, McDonald GB, Schubert M (1993) A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation. Blood 82:2025-2030 (Pubitemid 23293983)
34. White JR Jr, Rockwood T, Wilson D, Bettesworth L, Icenogle T (1994) The effects of pentoxifylline on the prevention of cyclosporine-induced nephrotoxicity in cardiac transplant patients. Clin Ther 16:673-679 (Abstract was used) (Pubitemid 24321696)
35. Carrier M, Pelletier GB, White M, Bois D, Pelletier LC (1996) Effect of pentoxifylline on renal toxicity of cyclosporine: results of a clinical trial after heart transplantation. J Heart Lung Transplant 15:1179-1183 (Pubitemid 26428392)
36. Frantz RP, Edwards BS, Olson LJ, Schwab MK, Adams TF, Textor SC, Daly RC, McGregor CG, Rodeheffer RJ (1997) Effects of pentoxifylline on renal function and blood pressure in cardiac transplant recipients: a randomized trial. Transplantation 63:1607-1610 (Pubitemid 27265502)
37. Königsrainer A, Aichberger C, Riedmann B, Steurer W, Ofner D, Margreiter R (1995) Pentoxifylline as an adjunct to cyclosporine-based immunosuppression does not improve the outcome of renal transplantation. Transplant Proc 27:1062-1063 (Abstract was used)
38. Noel C, Hazzan M, Labalette M, Coppin MC, Jude B, Dessaint JP, Lelievre G (1998) Improvement in the outcome of rejection with pentoxifylline in renal transplantation: a randomized controlled trial. Transplantation 65:385-389 (Pubitemid 28095967)
39. Kaynar K, Ersoz S, Aliyazicioglu R, Uzun A, Ulusoy S, Al S, Ozkan G, CansIz M (2012) Is there any way to protect from tacrolimus-induced renal and pancreas injury? Clin Transplant. doi: 10.1111/j.1399-0012.2012.01603.x [Epub ahead of print]
40. Deray G (2002) Amphotericin B, nephrotoxicity. J Antibicrob Chem 49:37-41
41. Laniado-Laborin R, Cabrales-Vargas MN (2009) Amphotericin B: side effects and toxicity. Rev Iberoam Micol 26:223-227
42. Sullivan GW, Carper HT, Mandell GL (1992) Pentoxifylline modulates activation of human neutrophils by amphotericin B in vitro. Antimicrob Agents Chemother 36:408-416
43. Luke DR, Wasan KM, McQueen TJ, Lopez-Berestein G (1990) Enhancement of the treatment of experimental candidiasis with vascular decongestants. J Infect Dis 162:211-214 (Pubitemid 20223972)
44. Wasan KM, Vadiei K, Lopez-Berestein G, Verani RR, Luke DR (1990) Pentoxifylline in amphotericin B toxicity rat model. Antimicrob Agents Chemother 34:241-244 (Pubitemid 20046873)
45. Kenedy MS, Deeg HJ, Siegel M, Crowley JJ, Storb R, Thomas ED (1983) Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation. Transplantation 35:211-215 (Pubitemid 13113788)
46. Balakumar P, Rohilla A, Thangathirupathi A (2010) Gentamicin-induced nephrotoxicity: do we have a promising therapeutic approach to blunt it? Pharmacol Res 62:179-186
47. Mimgeot-Leclercq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003-1012 (Pubitemid 29214718)
48. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Di Paola R, Britti D, De Sarro A, Pierpaoli S, Caputi A, Masini E, Salvemini D (2002) A role for superoxide in gentamicin-mediated nephropathy in rats. Eur J Pharmacol 450:67-76
49. Shah SV (1984) Effect of enzymatically generated reactive oxygen metabolites on the cyclic nucleotide content in isolated rat glomeruli. J Clin Invest 74:393-401 (Pubitemid 14053985)
50. Stojiljković N, Veljković S, Mihailović D, Stoiljković M, Ranković G, Jovanović I, Randjelović P (2009) Pentoxifylline ameliorates glomerular basement membrane ultrastructural changes caused by gentamicin administration in rats. Bosn J Basic Med Sci 9:239-244
51. Ozer MK, Asci H, Oncu M, Yesilot S, Savran M, Bayram D, Cicek E (2009) Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats. Ren Fail 31:134-139
52. Veiga JPR, Wolf ER, Sampaio RNR, Marsden PD (1983) Renal tubular dysfunction in patients with muco-cutaneous leishmaniasis treated with pentavalent antimonials. Lancet 2:569 (Pubitemid 13041575)
53. Marsden PD, Sampaio RNR, Carvalho EM, Veiga JPR, Costa JLM, Lianos-Cuentas EA (1985) High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis. AmJTrop Med Hyg 34:710-713 (Pubitemid 16237014)
54. Chulay JD, Fleckenstein L, Smith DH (1988) Pharmacokinetics of antimony during treatment of visceral leshmaniasis with sodium stibigluconate or meglumine antimonite. Trans R Soc Trop Med Hyg 82:69-72 (Pubitemid 18056241)
55. deMoura FJ, Leal PP, de Souza FR, Muniz-Junqueira MI, Veiga JP (2008) Pentoxifylline prevents the meglumineantimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride. Toxicology 243:66-74 (Pubitemid 350250960)
56. Gagliardi AR, Veiga JP, Rosa TT, Marsden PD (1985) Pentavalent antimonial inhibition of the osmotic effect of oxytocin on the isolated toad bladder. Braz J Med Biol Res 18:567-571 (Abstract was used) (Pubitemid 16128269)
57. Sleijfer DT, Meijer S, Mulder NH (1985) Cisplatin: a review of clinical applications and renal toxicity. Pharm Weekbl Sci 7:237-244 (Pubitemid 16234848)
58. Ferriere JM, Piechaud T, Gaston R, Brucher P, Grenier N, Leguillou M (1988) Cisplatin-based chemotherapy in the treatment of advanced stage tumors of bladder. Ann Urol Paris 22:442-445 (Pubitemid 19030810)
59. Jose B, Desmukh Y, Sharma SC (1984) Local control in advanced head and neck cancer by combined modalities of treatment. J Surg Oncol 26:230-232 (Pubitemid 14067766)
60. Arany I, Safirstein RL (2010) Cisplatin nephrotoxicity. Semin Nephrol 23:460-464
61. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB (2010) Mechanisms of Cisplatin nephrotoxicity. Toxins 2:2490-2518
62. Berens KL, Luke DR (1990) Pentoxifylline in the isolated perfused rat kidney. Transplanation 49:876-879 (Pubitemid 20171951)
63. Biolo G, Ciocchi B, Bosutti A, Situlin R, Toigo G, Guarnieri G (2002) Pentoxifylline acutely reduces protein catabolism in chronically uremic patients. Am J Kidney Dis 40:1162-1172 (Pubitemid 35403127)
64. Ramesh G, Reeves WB (2002) TNF-alpha mediates chemokine and cytokine expression and renal injury in Cisplatin nephrotoxicity. J Clin Invest 110:743-745
65. Chen YM, Chien CT, Hu-Tsai MI, Wu KD, Tsai CC, Wu MS, Tsai TJ (1999) Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis. Kidney Int 56:932-943 (Pubitemid 29411720)
66. Luke DR, Vadiei K, Lopez-Berestein G (1992) Role of vascular congestion in Cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 7:1-7
67. Kim YK, Choi TR, Kwon CH, Kim JH, Woo JS, Jung JS (2003) Beneficial effect of pentoxifylline on Cisplatin-induced acute renal failure in rabbits. Ren Fail 25:909-922 (Pubitemid 37487082)
68. Ciuffetti G, Mercuri M, Ott C, Lombardini R, Paltriccia R, Lupattelli G, Santambrogio L, Mannarino E (1991) Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Results of a double-blind placebo-controlled study. Eur J Clin Pharmacol 41:511-515
69. Franzini E, Sellak H, Hakim J, Pasquier C (1993) Oxidative damage to lysozyme by the hydroxyl radical: comparative effects of scavengers. Biochim Biophys Acta 1203:11-17 (Pubitemid 23348953)
70. Ward A, Clissold SP (1987) Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34:50-97 (Pubitemid 17092322)
71. Kruidering M, de Walter BV, de Heer E, Mulder GJ, Nagelkerke JF (1997) Cisplatin-induced nephrotoxicity in porcine proximal tubular cells, mitochondrial dysfunction by inhibition of complex I to IV of the respiratory chain. J Pharmacol Ezp Ther 280:638-649 (Pubitemid 27171323)
72. Saad SY, Najjar TA, Alashari M (2004) Role of non-selective adenosine receptor blockade and phosphodiesterase inhibition in Cisplatin-induced nephrogonadal toxicity in rats. Clin Exp Pharmacol Physiol 31:862-867 (Pubitemid 40052310)
73. Malarkodi KP, Balachandar AV, Varlakshmi P (2003) The influence of lipoic acid on adriamycin-induced hyperlipidemic nephrotoxicity in rats. Mol Cell Biochem 247:139-145 (Pubitemid 36798518)
74. Ozen S, Usta Y, Sahin-Erdemli I, Orhan D, Gumusel B, Yang B, Gursoy Y, Tulunary O, Dalkara T, Bakkaloglu A, El-Nahas M (2001) Association of nitric oxide production and apoptosis in a model of experimental nephropathy. Nephrol Dial Transplant 16:32-38 (Pubitemid 32051471)
75. Gomez-Chiarri M, Ortiz A, Lerma JL, Lopez-Armada MJ, Mampaso F, Gonzalez E, Egido J (1994) Involvement of tumornecrosis factor and platelet activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest 70:449-459 (Pubitemid 24185015)
76. Izzedine H, Launary-Vacher V, Karie S (2005) Is low-dose methotrexate nephrotoxic? Case report and review of the literature. Clin Nephrol 64:315-319 (Pubitemid 41448436)
77. Djerassi I (1975) High-dose methotrexate (NSC-740) and citrovorum factor (NSC-3590) rescue: back ground and rational. Cancer Chemother Rep 6:3-6
78. Asvadi I, Hajipour B, Asvadi A, Asl NA, Roshangar L, Khodadadi A (2011) Protective effect of pentoxyfilline in renal toxicity after methotrexate administration. Eur Rev Med Pharmacol Sci 15:1003-1009
79. Gleeson TG, Bulugahapitiya S (2004) Contrast-induced nephropathy. AJR Am J Roentgenol 183:1673-1689 (Pubitemid 44210538)
80. Roozbeh J, Hamidian Jahromi A, Sharifian M, Pakfetrat M, Afshariani R (2008) Protective effect of pentoxifylline on contrast induced nephropathy. Saudi J Kidney Dis Transpl 19:985-986
81. Firouzi A, Eshraghi A, Shakerian F, Sanati HR, Salehi N, Zahedmehr A, Kiani R, Madani M, Pedarzadeh A (2011) Efficacy of pentoxifylline in prevention of contrast-induced nephropathy in angioplasty patients. Int Urol Nephrol [Epub ahead of print]
82. http://clinicaltrial.gov/ct2/show/NCT01144091
83. http://clinicaltrial.gov/ct2/show/NCT01469624
84. Singh NP, Ganguli A, Prakash A (2003) Drug-induced kidney diseases. J Assoc Physicians India 51:970-979 (Pubitemid 41279842)
85. Bianco JA, Singer JW (1992) Response to: Pentoxifylline did not prevent transplant-related toxicity in 31 consecutive allogeneic bone marrow transplant recipients. Blood 80:2683-2684